Studies have identified leptin, aromatase, insulin receptor, peroxisome-proliferator-activated receptor gamma (PPARγ), and lifestyle changes as other potential targets for obesity-associated breast cancer treatment. Here, CYP19A1 is linked to breast carcinoma.